Safety Framework: Who Should and Should Not Consider This Approach Combination insulin-semaglutide therapy is contraindicated in type 1 diabetes, severe kidney disease (eGFR below 15), personal or family history of medullary thyroid carcinoma, and active diabetic ketoacidosis
They target different cell populations and different aging mechanisms
Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder
Currently, many patients find themselves trapped in a frustrating cycle: their doctor prescribes a GLP-1 for weight management or moderate-to-severe obstructive sleep apnea, but their employer-sponsored health insurance refuses to cover it
Avoid the fridge door, it warms up every time its opened
This means the post-injection side effect window is somewhat compressed compared to semaglutide